The Prostate testing for cancer and Treatment (ProtecT) randomized trial currently being conducted by British researchers will hopefully bring clarity to the debate on how to manage prostate-specific antigen- (PSA-) detected clinically localized prostate cancer.

In a first-of-its-kind pilot study, ultrasound microbubbles typically used as a contrast agent have shown they may be able to enhance the delivery and absorption of cancer drugs in those with advanced pancreatic cancer, according to findings presented last week at the International Contrast Ultrasound Society (ICUS) annual conference in Chicago.

Ultrasound (US), along with a clinical follow-up, could be a diagnostic alternative to detect thyroid nodule malignancy instead of repeating a biopsy following non-diagnostic fine-needle aspiration (FNA), according to a study published in the September issue of Radiology.

One is a long-established option for colorectal cancer screening, the other is still fighting for Medicare coverage but has proven to be effective in clinical studies. Over the last week, the Huffington Post has hosted four experts providing their take on whether patients should seek out colonoscopy or CT colonography.

The American Society for Radiation Oncology (ASTRO) expanded on its recommendations for the national Choosing Wisely campaign, adding five targeted treatment options to the list of procedures that should be carefully scrutinized before being prescribed.

A shorter course of androgen deprivation therapy (ADT) can improve quality of life for high-risk prostate cancer patients by helping them recover a normal testosterone level in a shorter amount of time, according to research presented at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting in San Francisco.

Follow-up on the largest randomized study of fractionation techniques for radiation treatment has shown that hyperfractionated radiotherapy improves local-regional control and overall survival at five years for patients with locally advanced squamous cell cancer compared with standard fractionation and other accelerated fractionation techniques. 

A big question mark sits over the topic of low-dose CT lung cancer screening.